Vysov M 50Mg/500Mg 10Tablet contains following Salts:-
Metformin - Drug Information
Typical usage: :Diabetes mellitus, Hyperlipoproteinaemia, Insulin dependent diabetes mellitus, Insulin resistance, Non-insulin dependent diabetes mellitus, Obesity.
Probable Side Effects: :Vasculitis, Pneumonitis, Malabsorption of vit B12, Malabsorpton of folic acid, Megaloblastic anemia, Hypoglycemia.
Drug Interaction: Additive effect with sulphonylureas. Glycaemic control may be affected by diuretics, corticosteroids, phenothiazines, thyroid products, oestrogens.
Mechanism of Action: The exact mechanism of action of metformin is unclear but it appears to reduce glucose absorption from the GI tract, reduce gluconeogenesis and enhance insulin sensitivity by increasing peripheral glucose uptake and utilisation.
Pregnancy Impact: Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use of the drug in pregnant women clearly outweigh potential benefits.
Impact During Lactation: Studies in breastfeeding mothers have demonstrated that there is significant and documented risk to the infant based on human experience, or it is a medication that has a high risk of causing significant damage to an infant. The risk of using the drug in breastfeeding women clearly outweighs any possible benefit from breastfeeding. The drug is contraindicated in women who are breastfeeding an infant.
Vildagliptin - Drug Information
Typical usage: :Type II diabetes mellitus.
Probable Side Effects: :Angioedema, muscle aches, fever, swelling of feet and lower legs, mild paresthesia, dizziness, headache, fatigue, Nausea, asthenia, hypoglycemia.
Drug Interaction: Tell your doctor of all prescription and nonprescription medication you may use. Do not start or stop any medicine without doctor or pharmacist approval.
Mechanism of Action: Vildagliptin inhibits dipeptidyl peptidase-4. This in turn inhibits the inactivation of GLP-1 by DPP-4, allowing GLP-1 to potentiate the secretion of insulin in the beta cells.
Pregnancy Impact: Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.
Impact During Lactation: There are no controlled studies in breastfeeding women, however the risk of untoward effects to a breastfed infant is possible; or, controlled studies show only minimal non-threatening adverse effects. Drugs should be given only if the potential benefit justifies the potential risk to the infant.
Price of Vysov M 50Mg/500Mg 10Tablet : Rs.241.50
|Dispatches by||Same Day|
|Composition||Metformin 500 mg, Vildagliptin 50 mg|
|Salt Information||Metformin, Vildagliptin|
|Brand Name||Emcure Pharma|
|Pack Size||10 Tablet|
Use spaces to separate tags. Use single quotes (') for phrases.
FAQ on Vysov M 50Mg/500Mg 10Tablet
There are no product questions yet.
We guarantee to ship your order next day after order has been submitted
Please contacts us and our customer service team will answer all your questions
If you are not satisfied with your order - send it back within 14 days after day of purchase!
Substitutes of Vysov M 50Mg/500Mg 10Tablet
Rs.1.00Cyper Drugs & Pharma
Rs.1.00Orchid Chemicals & Pharma
Rs.1.00Low Cost Standard Therapeutics (Locost)
- Mail Today
- Bio Spectrum
- The Financial Chronicle
- Business Standard
- News Informer
- Business Standard
- News Prelease
- Biznews Index
- 15 Minute News
- Biz Radar
- VNI India
- Khari News
- Hunt News
- Express Pharma
- Silicon India
- The Hindu
- Your Story
- Stratos Invest
- EPL India
- Hindustan Times
- The Times of India